Cytomegalovirus esophagitis precipitated with immunosuppression in elderly giant cell arteritis patients

Aging Clinical and Experimental Research

Volumn 25, Issue 2, 2013, Pages 215-218

  Akın, Sibel ^a   Tufan, Fatih ^a   Bahat, Gülistan ^a   Saka, Bülent ^a   Erten, Nilgün ^a   Karan, Mehmet Akif ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Corticosteroid treatment; Cytomegalovirus esophagitis; Giant cell arteritis

Indexed keywords

ACICLOVIR; CEFTRIAXONE; CLARITHROMYCIN; ENOXAPARIN; FLUCONAZOLE; GANCICLOVIR; MEPREDNISONE; SULTAMICILLIN; WARFARIN;

AGED; ARTICLE; CASE REPORT; CORTICOSTEROID THERAPY; CYTOMEGALOVIRUS INFECTION; ESOPHAGITIS; ESOPHAGUS CANDIDIASIS; FEMALE; GERIATRIC DISORDER; GIANT CELL ARTERITIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOCOMPROMISED PATIENT; IMMUNOSUPPRESSIVE TREATMENT; LUNG EMBOLISM; MALE; PNEUMONIA; THRUSH; URINARY TRACT INFECTION; VISUAL IMPAIRMENT;

CYTOMEGALOVIRUS;

EID: 84886647717     PISSN: 15940667     EISSN: 17208319     Source Type: Journal    
DOI: 10.1007/s40520-013-0019-8     Document Type: Article

References (24)

1. Hecker M, Qiu D, Marquardt K, Bein G, Hackstein H (2004) Continuous cytomegalovirus seroconversion in a large group of healthy blood donors. Vox Sang 86(1):41-44
2. Hillyer CD, Snydman DR, Berkman EM (1990) The risk of cytomegalovirus infection in solid organ and bone marrow transplant recipients: transfusion of blood products. Transfusion 30(7):659-666
3. Tyms AS, Taylor DL, Parkin JM (1989) Cytomegalovirus and the acquired immunodeficiency syndrome. J Antimicrob Chemother 23 Suppl A:89-105
4. Cohen JI, Corey GR (1985) Cytomegalovirus infection in the normal host. Medicine (Baltimore) 64(2):100-114
5. Horwitz CA, Henle W, Henle G, Snover D, Rudnick H, Balfour HH Jr, Mazur MH (1986) Clinical and laboratory evaluation of cytomegalovirus-induced mononucleosis in previously healthy individuals. Report of 82 cases. Medicine (Baltimore) 65(2):124-134
6. Gandhi MK, Khanna R (2004) Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatments. Lancet Infect Dis 4(12):725-738
7. Söderberg-Nauclér C, Fish KN, Nelson JA (1997) Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors. Cell 91(1):119-126
8. Almanzar G, Schwaiger S, Jenewein B, Keller M, Herndler-Brandstetter D, Wurzner R et al (2005) Longterm cytomegalovirus infection leads to significant changes in the composition of the CD8+ T-cell repertoire, which may be the basis for an imbalance in the cytokine production profile in elderly persons. J Virol 79(6):3675-3683
9. Olsson J, Wikby A, Johansson B, Lofgren S, Nilsson BO, Ferguson FG (2000) Age-related change in peripheral blood T-lymphocyte subpopulations and cytomegalovirus infection in the very old: the Swedish longitudinal OCTO immune study. Mech Ageing Dev 121(1-3):187-201
10. Wikby A, Johansson B, Olsson J, Lofgren S, Nilsson BO, Ferguson F (2002) Expansions of peripheral blood CD8 T-lymphocyte subpopulations and an association with cytomegalovirus seropositivity in the elderly: the Swedish NONA immune study. Exp Gerontol 37(2-3):445-453
11. Cook CH, Martin LC, Yenchar JK, Lahm MC, McGuinness B, Davies EA et al (2003) Occult herpes family viral infections are endemic in critically ill surgical patients. Crit Care Med 31(7):1923-1929
12. Cook CH, Yenchar JK, Kraner TO, Davies EA, Ferguson RM (1998) Occult herpes family viruses may increase mortality in critically ill surgical patients. Am J Surg 176(4):357-360
13. Cook CH, Zhang Y, Sedmak DD, Martin LC, Jewell S, Ferguson RM (2006) Pulmonary cytomegalovirus reactivation causes pathology in immunocompetent mice. Crit Care Med 4(3):842-849
14. Heininger A, Jahn G, Engel C, Notheisen T, Unertl K, Hamprecht K (2001) Human cytomegalovirus infections in nonimmunosuppressed critically ill patients. Crit Care Med 29(3):541-547
15. Jaber S, Chanques G, Borry J, Souche B, Verdier R, Perrigault PF et al (2005) Cytomegalovirus infection in critically ill patients: associated factors and consequences. Chest 127(1):233-241
16. Limaye AP, Kirby KA, Rubenfeld GD, Leisenring WM, Bulger EM, Neff MJ et al (2008) Cytomegalovirus reactivation in critically ill immunocompetent patients. JAMA 300(4):413-422
17. Buckner FS, Pomeroy C (1993) Cytomegalovirus disease of the gastrointestinal tract in patients without AIDS. Clin Infect Dis 17(4):644-656
18. Rafailidis PI, Mourtzoukou EG, Varbobitis IC, Falagas ME (2008) Severe cytomegalovirus infection in apparently immunocompetent patients: a systematic review. Virol J 5:47
19. Weile J, Streeck B, Muck J, Krebs G, Jakobus KH, Knabbe C et al (2009) Severe cytomegalovirus-associated esophagitis in an immunocompetent patient after short-term steroid therapy: a case-report. J Clin Microbiol 47(9):3031-3033
20. Axelrod D, Leventhal JR, Gallon LG, Parker MA, Kaufman DB (2005) Reduction of CMV disease with steroid-free immunosuppression in simultaneous pancreas-kidney transplant recipients. Am J Transplant 5(6):1423-1429
21. Brunner S, Herndler-Brandstetter D, Weinberger B, Grubeck-Loebenstein B (2011) Persistent viral infections and immune aging. Ageing Res Rev 10(3):362-369
22. Fest T, Mougin C, Dupond JL (1996) Giant cell arteritis. Ann Intern Med 124(10):927-928
23. Helweg-Larsen J, Tarp B, Obel N, Baslund B (2002) No evidence of parvovirus B19, Chlamydia pneumoniae or human herpes virus infection in temporal artery biopsies in patients with giant cell arteritis. Rheumatology (Oxford) 41(4):445-449
24. Muller WJ, Jones CA, Koelle DM (2010) Immunobiology of herpes simplex virus and cytomegalovirus infections of the fetus and newborn. Curr Immunol Rev 6(1):38-55